{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:21:17Z","timestamp":1781796077428,"version":"3.54.5"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Drug-induced delayed hypersensitivity reactions (DHRs) is still a clinical and healthcare burden in every country. Increasing reports of DHRs have caught our attention to explore the genetic relationship, especially life-threatening severe cutaneous adverse drug reactions (SCARs), including acute generalized exanthematous pustulosis (AGEP), drug reactions with eosinophilia and systemic symptoms (DRESS), Stevens\u2013Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). In recent years, many studies have investigated the immune mechanism and genetic markers of DHRs. Besides, several studies have stated the associations between antibiotics-as well as anti-osteoporotic drugs (AOD)-induced SCARs and specific human leukocyte antigens (HLA) alleles. Strong associations between drugs and HLA alleles such as co-trimoxazole-induced DRESS and <jats:italic>HLA-B*13:01<\/jats:italic> (Odds ratio (OR) = 45), dapsone-DRESS and <jats:italic>HLA-B*13:01<\/jats:italic> (OR = 122.1), vancomycin-DRESS and <jats:italic>HLA-A*32:01<\/jats:italic> (OR = 403), clindamycin-DHRs and <jats:italic>HLA-B*15:27<\/jats:italic> (OR = 55.6), and strontium ranelate (SR)-SJS\/TEN and <jats:italic>HLA-A*33:03<\/jats:italic> (OR = 25.97) are listed. We summarized the immune mechanism of SCARs, update the latest knowledge of pharmacogenomics of antibiotics- and AOD-induced SCARs, and indicate the potential clinical use of these genetic markers for SCARs prevention in this mini review article.<\/jats:p>","DOI":"10.3389\/fphar.2023.1183491","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:10:50Z","timestamp":1682485850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs"],"prefix":"10.3389","volume":"14","author":[{"given":"Chih-Hsuan","family":"Wung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ti","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuen-Iu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Taiwan Severe Cutaneous Adverse Reaction Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.2174\/1381612825666190628160603","article-title":"Reviewing the mechanistic evidence assessors E-synthesis and EBM+: A case study of amoxicillin and drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"25","author":"Abdin","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"B2","unstructured":"Table of pharmacogenomic biomarkers in drug labeling\n            AdministrationU. S. F.\n          2023"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11926-017-0626-z","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and the rheumatologist","volume":"19","author":"Adwan","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/bjd.14649","article-title":"Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A disproportionality analysis using the French pharmacovigilance database","volume":"175","author":"Agier","year":"2016","journal-title":"Br. J. Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.5005\/jp-journals-10071-23826","article-title":"Drug-related stevens\u2013johnson syndrome and toxic epidermal necrolysis: A review","volume":"25","author":"Arora","year":"2021","journal-title":"Indian J. Crit. Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/DHPS.S347522","article-title":"Clinical manifestations and genetic influences in sulfonamide-induced hypersensitivity","volume":"14","author":"Asyraf","year":"2022","journal-title":"Drug Healthc. Patient Saf."},{"key":"B7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/FPC.0000000000000118","article-title":"PharmGKB summary: Very important pharmacogene information for human leukocyte antigen B","volume":"25","author":"Barbarino","year":"2015","journal-title":"Pharmacogenet Genomics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"959321","DOI":"10.3389\/fphar.2022.959321","article-title":"LTT and HLA testing as diagnostic tools in Spanish vancomycin-induced DRESS cases: A case-control study","volume":"13","author":"Bellon","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.21037\/tgh.2017.11.16","article-title":"Mortality associated with drug-induced liver injury (DILI)","volume":"2","author":"Bjornsson","year":"2017","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.clindermatol.2020.06.008","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"38","author":"Cardones","year":"2020","journal-title":"Clin. Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3389\/fphar.2020.00969","article-title":"Pharmacogenetic testing for prevention of severe cutaneous adverse drug reactions","volume":"11","author":"Chang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/jdv.16924","article-title":"The risk of anti-osteoporotic agent-induced severe cutaneous adverse drug reactions and their association with HLA","volume":"35","author":"Chen","year":"2021","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"6431694","DOI":"10.1155\/2018\/6431694","article-title":"An updated review of the molecular mechanisms in drug hypersensitivity","volume":"2018","author":"Chen","year":"2018","journal-title":"J. Immunol. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/jdv.16924","article-title":"The risk of anti-osteoporotic agent-induced severe cutaneous adverse drug reactions and their association with HLA","volume":"35","author":"Chen","year":"2021","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.jid.2018.02.004","article-title":"The function of HLA-B*13:01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions","volume":"138","author":"Chen","year":"2018","journal-title":"J. Invest. Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/14656566.2020.1721467","article-title":"Treatment options for glucocorticoid-induced osteoporosis","volume":"21","author":"Chiodini","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat. Med."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.5070\/d3266049312","article-title":"A case of vancomycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome with failure to respond to cyclosporine treatment","volume":"26","author":"Clark","year":"2020","journal-title":"Dermatology Online J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"573573","DOI":"10.3389\/fphar.2020.573573","article-title":"An updated review of the diagnostic methods in delayed drug hypersensitivity","volume":"11","author":"Copaescu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","article-title":"Human leukocyte antigen (HLA) and immune regulation: How do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections?","volume":"8","author":"Crux","year":"2017","journal-title":"Front. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"891838","DOI":"10.3389\/fphar.2022.891838","article-title":"Distribution of HLA-B alleles and haplotypes in Qatari: Recommendation for establishing pharmacogenomic markers screening for drug hypersensitivity","volume":"13","author":"Dashti","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/ACI.0000000000000665","article-title":"Adverse reactions to vancomycin and cross-reactivity with other antibiotics","volume":"20","author":"De Luca","year":"2020","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/jisprm.jisprm_17_18","article-title":"Postbreast cancer surgery outpatient rehabilitation program: Analysis of clinical profile, impact, and direct medical costs","volume":"63","author":"de Sousa","year":"2018","journal-title":"Indian J. Dermatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41598-020-57776-3","article-title":"The antibiotic vancomycin induces complexation and aggregation of gastrointestinal and submaxillary mucins","volume":"10","author":"Dinu","year":"2020","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nm.4023","article-title":"Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites","volume":"22","author":"Dotiwala","year":"2016","journal-title":"Nat. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.it.2013.11.003","article-title":"Pathogenic memory type Th2 cells in allergic inflammation","volume":"35","author":"Endo","year":"2014","journal-title":"Trends Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3186328","DOI":"10.1155\/2017\/3186328","article-title":"HLA association with drug-induced adverse reactions","volume":"2017","author":"Fan","year":"2017","journal-title":"J. Immunol. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.3390\/ijms17081214","article-title":"Acute generalized exanthematous pustulosis: Pathogenesis, genetic background, clinical variants and therapy","volume":"17","author":"Feldmeyer","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1189\/jlb.3RI1014-495R","article-title":"Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions","volume":"97","author":"Gabay","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/cod.13005","article-title":"Acute generalized exanthematous pustulosis induced by oxacillin confirmed by patch testing","volume":"79","author":"Gammoudi","year":"2018","journal-title":"Contact Dermat."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/ijms22031127","article-title":"Drug reaction with eosinophilia and systemic symptoms: A complex interplay between drug, T cells, and herpesviridae","volume":"22","author":"Ganeshanandan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-4939-8546-3_4","article-title":"Allele frequency Net database","volume":"1802","author":"Gonzalez-Galarza","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.35460\/2546-1621.2017-0031","article-title":"Epidemiology of severe cutaneous adverse drug reactions in a university hospital: A five-year review","volume":"2","author":"Guzman","year":"2018","journal-title":"J. Med. Univ. Santo Tomas"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/Drug reaction with eosinophilia and systemic symptoms (DRESS): Clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.3390\/ijerph19052833","article-title":"Trimethoprim-sulfamethoxazole (bactrim) dose optimization in Pneumocystis jirovecii pneumonia (PCP) management: A systematic review","volume":"19","author":"Haseeb","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.24748.1","article-title":"Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"9","author":"Hasegawa","year":"2020","journal-title":"F1000Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jfma.2021.09.025","article-title":"Analysis of severe cutaneous adverse reactions (SCARs) in taiwan drug-injury relief system: 18-year results","volume":"121","author":"Huang","year":"2022","journal-title":"J. Formos. Med. Assoc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/biomedicines10061260","article-title":"Immediate hypersensitivity reactions induced by COVID-19 vaccines: Current trends, potential mechanisms and prevention strategies","volume":"10","author":"Hung","year":"2022","journal-title":"Biomedicines"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0252161","DOI":"10.1371\/journal.pone.0252161","article-title":"Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis","volume":"16","author":"Insani","year":"2021","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1080\/17425255.2021.1946514","article-title":"Genotyping HLA alleles to predict the development of severe cutaneous adverse drug reactions (SCARs): State-of-the-art","volume":"17","author":"Jantararoungtong","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"ofac327","DOI":"10.1093\/ofid\/ofac327","article-title":"Antibiotics for preventing recurrent urinary tract infection: Systematic review and meta-analysis","volume":"9","author":"Jent","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12929-022-00845-8","article-title":"Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity","volume":"29","author":"Jiang","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3904\/kjim.2018.126","article-title":"Genetic markers of severe cutaneous adverse reactions","volume":"33","author":"Jung","year":"2018","journal-title":"Korean J. Intern Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jaip.2020.09.011","article-title":"A nationwide study of severe cutaneous adverse reactions based on the multicenter registry in Korea","volume":"9","author":"Kang","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.5415\/apallergy.2020.10.e2","article-title":"Altered T cell and monocyte subsets in prolonged immune reconstitution inflammatory syndrome related with DRESS (drug reaction with eosinophilia and systemic symptoms)","volume":"10","author":"Kang","year":"2020","journal-title":"Asia Pac Allergy"},{"key":"B50","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4168\/aair.2021.13.6.896","article-title":"The role of in vitro detection of drug-specific mediator-releasing cells to diagnose different phenotypes of severe cutaneous adverse reactions","volume":"13","author":"Klaewsongkram","year":"2021","journal-title":"Allergy Asthma Immunol. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/ph14111077","article-title":"A comprehensive review of HLA and severe cutaneous adverse drug reactions: Implication for clinical pharmacogenomics and precision medicine","volume":"14","author":"Kloypan","year":"2021","journal-title":"Pharmaceuticals"},{"key":"B52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.alit.2017.06.001","article-title":"The thymus and activation-regulated chemokine (TARC) level in serum at an early stage of a drug eruption is a prognostic biomarker of severity of systemic inflammation","volume":"67","author":"Komatsu-Fujii","year":"2018","journal-title":"Allergol. Int."},{"key":"B53","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/FPC.0000000000000153","article-title":"Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions","volume":"25","author":"Kongpan","year":"2015","journal-title":"Pharmacogenet Genomics"},{"key":"B54","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ajhg.2020.08.008","article-title":"Genome-wide study identifies association between HLA-B(*)55:01 and self-reported penicillin allergy","volume":"107","author":"Krebs","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0008746","DOI":"10.1371\/journal.pntd.0008746","article-title":"Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia","volume":"14","author":"Krismawati","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/jdv.16339","article-title":"Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN)","volume":"34","author":"Kuijper","year":"2020","journal-title":"J. Eur. Acad. Dermatol Venereol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e26219","DOI":"10.7759\/cureus.26219","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome due to vancomycin","volume":"14","author":"Kulkarni","year":"2022","journal-title":"Cureus"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1007\/s00198-016-3568-9","article-title":"Increased risk of strontium ranelate-related SJS\/TEN is associated with HLA","volume":"27","author":"Lee","year":"2016","journal-title":"Osteoporos. Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e12098","DOI":"10.1002\/clt2.12098","article-title":"Reducing severe cutaneous adverse and type B adverse drug reactions using pre-stored human leukocyte antigen genotypes","volume":"12","author":"Lee","year":"2022","journal-title":"Clin. Transl. Allergy"},{"key":"B61","doi-asserted-by":"publisher","first-page":"12443","DOI":"10.3390\/ijms232012443","article-title":"Drug resistance (dapsone, rifampicin, ofloxacin) and resistance-related gene mutation features in leprosy patients: A systematic review and meta-analysis","volume":"23","author":"Li","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/cid\/ciu126","article-title":"Severe cutaneous adverse reactions related to systemic antibiotics","volume":"58","author":"Lin","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jamadermatol.2018.5360","article-title":"Evaluation of prospective HLA-B*13:01 screening to prevent dapsone hypersensitivity syndrome in patients with leprosy","volume":"155","author":"Liu","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"109250","DOI":"10.1016\/j.clim.2023.109250","article-title":"DNA methylation of ITGB2 contributes to allopurinol hypersensitivity","volume":"248","author":"Liu","year":"2023","journal-title":"Clin. Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e23068","DOI":"10.1097\/MD.0000000000023068","article-title":"Association between mutation of interleukin 36 receptor antagonist and generalized pustular psoriasis: A PRISMA-compliant systematic review and meta-analysis","volume":"99","author":"Liu","year":"2020","journal-title":"Med. Baltim."},{"key":"B66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.3390\/jcm10194486","article-title":"A network analysis of drug combinations associated with acute generalized exanthematous pustulosis (AGEP)","volume":"10","author":"Martinez-De la Torre","year":"2021","journal-title":"J. Clin. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1001\/archinte.163.4.402","article-title":"Trimethoprim-sulfamethoxazole revisited","volume":"163","author":"Masters","year":"2003","journal-title":"Archives Intern. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41423-020-0412-0","article-title":"Neutrophil chemoattractant receptors in health and disease: Double-edged swords","volume":"17","author":"Metzemaekers","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.anai.2016.03.030","article-title":"Immune-mediated reactions to vancomycin: A systematic case review and analysis","volume":"116","author":"Minhas","year":"2016","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/biom11060847","article-title":"Chemokines in severe cutaneous adverse reactions (SCARs)","volume":"11","author":"Miyagawa","year":"2021","journal-title":"Biomolecules"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/ijms22042147","article-title":"Current perspective regarding the immunopathogenesis of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS)","volume":"22","author":"Miyagawa","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000335612","article-title":"Epidemiology of cutaneous adverse drug reactions","volume":"97","author":"Mockenhaupt","year":"2012","journal-title":"Chem. Immunol. Allergy"},{"key":"B75","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11882-018-0778-6","article-title":"Severe cutaneous adverse drug reactions: Presentation, risk factors, and management","volume":"18","author":"Mustafa","year":"2018","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jid.2019.12.025","article-title":"Association of HLA-A*11:01 with sulfonamide-related severe cutaneous adverse reactions in Japanese patients","volume":"140","author":"Nakamura","year":"2020","journal-title":"J. Invest. Dermatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jaci.2020.04.056","article-title":"Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A *32:01-positive vancomycin-induced DRESS sharing an HLA class II haplotype","volume":"147","author":"Nakkam","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.dmpk.2022.100480","article-title":"Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions","volume":"47","author":"Nakkam","year":"2022","journal-title":"Drug Metabolism Pharmacokinet."},{"key":"B79","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/08820538.2021.1893764","article-title":"Stevens johnson syndrome: A review of a vision and life-threatening mucocutaneous disease including histopathology with updates on pathogenesis and genetic risk factors","volume":"36","author":"Neerukonda","year":"2021","journal-title":"Semin. Ophthalmol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2217\/pgs-2017-0090","article-title":"HLA-associated drug hypersensitivity and the prediction of adverse drug reactions","volume":"18","author":"Negrini","year":"2017","journal-title":"Pharmacogenomics"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jaci.2020.10.004","article-title":"Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort","volume":"147","author":"Nicoletti","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/ijd.15287","article-title":"Differences between Stevens-Johnson syndrome versus toxic epidermal necrolysis","volume":"60","author":"Nowsheen","year":"2021","journal-title":"Int. J. Dermatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/toxsci\/kfab084","article-title":"Deciphering adverse drug reactions: In vitro priming and characterization of vancomycin-specific T cells from healthy donors expressing HLA-A*32:01","volume":"183","author":"Ogese","year":"2021","journal-title":"Toxicol. Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdin.2020.12.004","article-title":"Acute generalized exanthematous pustulosis: Epidemiology, clinical course, and treatment outcomes of patients treated in an Asian academic medical center","volume":"3","author":"Oh","year":"2021","journal-title":"JAAD Int."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.11.024","article-title":"TNF-\u03b1\u2012Mediated keratinocyte expression and release of matrix metalloproteinase 9: Putative mechanism of pathogenesis in stevens\u2012johnson syndrome\/toxic epidermal necrolysis","author":"Olsson-Brown","year":"2022","journal-title":"J. Investigative Dermatology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.mcna.2021.04.001","article-title":"Recognition and management of severe cutaneous adverse drug reactions (including drug reaction with eosinophilia and systemic symptoms, stevens-johnson syndrome, and toxic epidermal necrolysis)","volume":"105","author":"Owen","year":"2021","journal-title":"Med. Clin. North Am."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1080\/14740338.2020.1796965","article-title":"The HLA-B*13:01 and the dapsone hypersensitivity syndrome in Korean and asian populations: Genotype- and meta-analyses","volume":"19","author":"Park","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"B88","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ijd.15144","article-title":"Stevens-johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: A review of published cases","volume":"60","author":"Pej\u010di\u0107","year":"2021","journal-title":"Int. J. Dermatology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"key":"B90","first-page":"35","article-title":"A case of vancomycin-induced acute generalized exanthematous pustulosis confirmed by patch testing","volume":"13","author":"Pettit","year":"2020","journal-title":"J. Clin. aesthetic dermatology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/all.15558","article-title":"Viral infections and drug hypersensitivity","volume":"78","author":"Pichler","year":"2022","journal-title":"Allergy"},{"key":"B92","doi-asserted-by":"publisher","first-page":"8790","DOI":"10.3390\/ijms21228790","article-title":"The immune functions of keratinocytes in skin wound healing","volume":"21","author":"Piipponen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jaci.2019.04.009","article-title":"HLA- and immune-mediated adverse drug reactions: Another hit with vancomycin","volume":"144","author":"Pirmohamed","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"658593","DOI":"10.3389\/fimmu.2021.658593","article-title":"Characterization of T-cell responses to SMX and SMX-NO in Co-trimoxazole hypersensitivity patients expressing HLA-B*13:01","volume":"12","author":"Pratoomwun","year":"2021","journal-title":"Front. Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fgene.2014.00478","article-title":"HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: Evidence for high risk of drug-induced hypersensitivity","volume":"5","author":"Puangpetch","year":"2014","journal-title":"Front. Genet."},{"key":"B96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5935\/0305-7518.20010009","article-title":"Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal","volume":"72","author":"Rao","year":"2001","journal-title":"Lepr. Rev."},{"key":"B97","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s40257-020-00584-2","article-title":"Dermatitis herpetiformis: An update on diagnosis and management","volume":"22","author":"Reunala","year":"2021","journal-title":"Am. J. Clin. Dermatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/all.15147","article-title":"Next-generation sequencing and genotype association studies reveal the association of HLA-DRB3*02:02 with delayed hypersensitivity to penicillins","volume":"77","author":"Romano","year":"2022","journal-title":"Allergy"},{"key":"B99","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaip.2016.10.008","article-title":"HLA B62 as a possible risk factor for drug reaction with eosinophilia and systemic symptoms to piperacillin\/tazobactam","volume":"5","author":"Rutkowski","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B100","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jmoldx.2019.04.006","article-title":"A rapid allele-specific assay for HLA-A*32:01 to identify patients at risk for vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"21","author":"Rwandamuriye","year":"2019","journal-title":"J. Mol. Diagn"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1076029620950831","DOI":"10.1177\/1076029620950831","article-title":"The role of IL-13, IL-15 and granulysin in the pathogenesis of stevens-johnson syndrome\/toxic epidermal necrolysis","volume":"27","author":"Sadek","year":"2021","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"B102","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2133.2012.10921.x","article-title":"Prolonged elevation of serum granulysin in drug-induced hypersensitivity syndrome","volume":"167","author":"Saito","year":"2012","journal-title":"Br. J. Dermatol"},{"key":"B103","doi-asserted-by":"crossref","first-page":"245ra95","DOI":"10.1126\/scitranslmed.3008227","article-title":"An annexin A1\u2013FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions","volume":"6","author":"Saito","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"661135","DOI":"10.3389\/fimmu.2021.661135","article-title":"HLA-B*13:01 is a predictive marker of dapsone-induced severe cutaneous adverse reactions in Thai patients","volume":"12","author":"Satapornpong","year":"2021","journal-title":"Front. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s13671-021-00348-z","article-title":"Updates and insights in the diagnosis and management of DRESS syndrome","volume":"10","author":"Schunkert","year":"2021","journal-title":"Curr. Dermatol Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00228-020-03005-9","article-title":"Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A literature review","volume":"77","author":"Sharifzadeh","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol. Int."},{"key":"B108","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12911-015-0139-5","article-title":"GraphSAW: A web-based system for graphical analysis of drug interactions and side effects using pharmaceutical and molecular data","volume":"15","author":"Shoshi","year":"2015","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"B109","doi-asserted-by":"publisher","first-page":"197","DOI":"10.12932\/AP-271118-0449","article-title":"Association of HLA genotypes with Beta-lactam antibiotic hypersensitivity in children","volume":"39","author":"Singvijarn","year":"2021","journal-title":"Asian Pac J. Allergy Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1016\/j.jemermed.2021.03.007","article-title":"Images in emergency medicine: Acute generalized exanthematous pustulosis","volume":"61","author":"Spadaro","year":"2021","journal-title":"J. Emerg. Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jid.2017.01.003","article-title":"Stevens-johnson syndrome and toxic epidermal necrolysis: Associations, outcomes, and pathobiology-thirty years of progress but still much to Be done","volume":"137","author":"Stern","year":"2017","journal-title":"J. Invest. Dermatol"},{"key":"B112","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/biomedicines10050999","article-title":"Drug reaction with eosinophilia and systemic symptoms (DReSS)\/Drug-Induced hypersensitivity syndrome (DiHS)\u2014readdressing the DReSS","volume":"10","author":"Stirton, H., N.H. Shear, and R.P. Dodiuk-Gad","year":"2022","journal-title":"Biomedicines"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jid.2016.11.034","article-title":"Interleukin-15 is associated with severity and mortality in stevens-johnson syndrome\/toxic epidermal necrolysis","volume":"137","author":"Su","year":"2017","journal-title":"J. Invest. Dermatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/cpt.1915","article-title":"Genetic association of Co-Trimoxazole-Induced severe cutaneous adverse reactions is phenotype-specific: HLA class I genotypes and haplotypes","volume":"108","author":"Sukasem","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B115","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jdcr.2022.02.009","article-title":"Acute generalized exanthematous pustulosis sine pustules: A case series","volume":"23","author":"Svoboda","year":"2022","journal-title":"JAAD Case Rep."},{"key":"B116","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","article-title":"Acute generalized exanthematous pustulosis (AGEP): A review and update","volume":"73","author":"Szatkowski","year":"2015","journal-title":"J. Am. Acad. Dermatol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamadermatol.2017.6484","article-title":"Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: A systematic review and meta-analysis","volume":"154","author":"Tangamornsuksan","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"832048","DOI":"10.3389\/fphar.2022.832048","article-title":"Drug-induced severe cutaneous adverse reactions: Insights into clinical presentation, immunopathogenesis, diagnostic methods, treatment, and pharmacogenomics","volume":"13","author":"Tempark","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/FPC.0000000000000306","article-title":"Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population","volume":"27","author":"Tempark","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1182\/blood-2010-03-273953","article-title":"Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin","volume":"116","author":"Tewary","year":"2010","journal-title":"Blood"},{"key":"B121","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/ACI.0b013e328355b865","article-title":"Immunological mechanisms of epidermal damage in toxic epidermal necrolysis","volume":"12","author":"Tohyama","year":"2012","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1365-2133.2011.10649.x","article-title":"Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","volume":"166","author":"Tohyama","year":"2012","journal-title":"Br. J. Dermatology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1111\/jdv.16664","article-title":"A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue","volume":"34","author":"Torres-Navarro","year":"2020","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/cea.13252","article-title":"Monocytes are involved in the balance between regulatory T cells and Th17 cells in severe drug eruptions","volume":"48","author":"Ushigome","year":"2018","journal-title":"Clin. Exp. Allergy"},{"key":"B125","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.mjafi.2013.01.007","article-title":"Severe cutaneous adverse drug reactions","volume":"69","author":"Verma","year":"2013","journal-title":"Med. J. Armed Forces India"},{"key":"B126","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/archdermatol.2011.104","article-title":"Endothelial damage in all types of T-lymphocyte\u2013mediated drug-induced eruptions","volume":"147","author":"Verneuil","year":"2011","journal-title":"Archives Dermatology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1046\/j.1523-1747.2000.00115.x","article-title":"A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin","volume":"115","author":"Vestergaard","year":"2000","journal-title":"J. Invest. Dermatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s13555-017-0206-1","article-title":"Acute localized exanthematous pustulosis (ALEP): Review of literature with report of case caused by amoxicillin-clavulanic acid","volume":"7","author":"Villani","year":"2017","journal-title":"Dermatol Ther. (Heidelb)"},{"key":"B129","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.iac.2022.01.002","article-title":"Advances in the pathomechanisms of delayed drug hypersensitivity","volume":"42","author":"Wang","year":"2022","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"B130","doi-asserted-by":"publisher","first-page":"954596","DOI":"10.3389\/fphar.2022.954596","article-title":"Associations of HLA-A and HLA-B with vancomycin-induced drug reaction with eosinophilia and systemic symptoms in the Han-Chinese population","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"886377","DOI":"10.3389\/fphar.2022.886377","article-title":"An updated review of genetic associations with severe adverse drug reactions: Translation and implementation of pharmacogenomic testing in clinical practice","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","article-title":"Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians","volume":"147","author":"Wang","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1038\/jid.2013.192","article-title":"Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China","volume":"133","author":"Wang","year":"2013","journal-title":"J. Invest. Dermatol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/ijd.13350","article-title":"Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression","volume":"55","author":"Weinborn","year":"2016","journal-title":"Int. J. Dermatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.emc.2021.09.001","article-title":"Drug hypersensitivity reactions","volume":"40","author":"Wilkerson","year":"2022","journal-title":"Emerg. Med. Clin. North Am."},{"key":"B136","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module","volume":"7","author":"Wolfson","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B137","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/archderm.131.5.544","article-title":"Metabolic predisposition to cutaneous adverse drug reactions: Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants","volume":"131","author":"Wolkenstein","year":"1995","journal-title":"Archives Dermatology"},{"key":"B138","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4168\/aair.2021.13.2.284","article-title":"Piperacillin-tazobactam allergies: An exception to usual penicillin allergy","volume":"13","author":"Wong","year":"2021","journal-title":"Allergy Asthma Immunol. Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/jpm11080775","article-title":"Associations between metabolic syndrome and obesity-related indices and bone mineral density T-score in hemodialysis patients","volume":"11","author":"Wung","year":"2021","journal-title":"J. Pers. Med."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00198-014-2688-3","article-title":"Strontium ranelate related stevens-johnson syndrome: A case report","volume":"25","author":"Yang","year":"2014","journal-title":"Osteoporos. Int."},{"key":"B141","doi-asserted-by":"publisher","first-page":"e0165933","DOI":"10.1371\/journal.pone.0165933","article-title":"Incidence of stevens-johnson syndrome and toxic epidermal necrolysis: A nationwide population-based study using national health insurance database in Korea","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"B142","doi-asserted-by":"publisher","first-page":"652091","DOI":"10.3389\/fmed.2021.652091","article-title":"Genetics of severe cutaneous adverse reactions","volume":"8","author":"Yang","year":"2021","journal-title":"Front. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/tpj.2016.61","article-title":"HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions","volume":"17","author":"Yang","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"B144","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/imj.12462","article-title":"Vancomycin-associated drug reaction with eosinophilia and systemic symptoms syndrome","volume":"44","author":"Young","year":"2014","journal-title":"Intern Med. J."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B*13:01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1016\/j.jid.2021.03.014","article-title":"HLA class-II\u2012restricted CD8(+) T cells contribute to the promiscuous immune response in dapsone-hypersensitive patients","volume":"141","author":"Zhao","year":"2021","journal-title":"J. Invest. Dermatol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1183491\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:10:59Z","timestamp":1682485859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1183491\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":147,"alternative-id":["10.3389\/fphar.2023.1183491"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1183491","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"article-number":"1183491"}}